MS and COVID-19 vaccination: What do we have to consider?

Join Professor Frauke Zipp and Professor Gregory Poland for the second interactive multiple sclerosis (MS) seminar of Janssen’s Neuroscience Medical Education (NSME) Forum for a unique opportunity to discuss the implications of the COVID-19 vaccines with a vaccine expert. This is a continuation of a new interdisciplinary and interactive series providing the opportunity to gain valuable insights from leading experts and a chance to participate in discussions around some of the most pertinent topics in the MS field.

During this interactive seminar, you can join Prof. Zipp and Prof. Poland in discussions on the key considerations relating to COVID-19 vaccination for patients with MS. This is an excellent opportunity to have your questions surrounding the use of vaccines in patients with MS answered by a leading vaccine researcher.

Please note that this programme has been submitted to the European Accreditation Committee in CNS (EACIC) for accreditation.

Learning objectives:

After this webinar, participants should be able to:

• Discuss implications of COVID-19 vaccination for MS patients
• Explore how COVID-19 vaccination could affect patients taking immunosuppressant DMTs
• Consider the potential concerns and benefits for MS patients regarding COVID-19 vaccination

Faculty:

• Prof. Frauke Zipp, Germany
• Prof. Gregory Poland, USA